about
All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2Altered nociception, analgesia and aggression in mice lacking the receptor for substance PFunctional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the ratWind-up of spinal cord neurones and pain sensation: much ado about something?GABAergic activity of quisqualamine and homoquisqualamine in hemisected spinal cord in vitro preparation.Antinociception and the new COX inhibitors: research approaches and clinical perspectives.Nitroparacetamol (NCX-701) and pain: first in a series of novel analgesics.Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. II. Effects after intrathecal administration.Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. I. Effects after oral administration.The oral administration of retinoic acid enhances nociceptive withdrawal reflexes in rats with soft-tissue inflammation.Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID.The antinociceptive effect of systemic gabapentin is related to the type of sensitization-induced hyperalgesia.The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up.Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes.Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and opioid receptors in spinal cord nociceptive reflexes.The antinociceptive effect of the mu-opioid fentanyl is reduced in the presence of the alpha(2)-adrenergic antagonist idazoxan in inflammation.The effects of sham and full spinalization on the antinociceptive effects of NCX-701 (nitroparacetamol) in monoarthritic rats.Spinal vs. supraspinal antinociceptive activity of the adenosine A(1) receptor agonist cyclopentyl-adenosine in rats with inflammation.Subanalgesic doses of dexketoprofen and HCT-2037 (nitrodexketoprofen) enhance fentanyl antinociception in monoarthritic rats.Enhancement of wind-up by the combined administration of adenosine A1 receptor ligands on spinalized rats with carrageenan-induced inflammation.The antinociceptive effects of the systemic adenosine A1 receptor agonist CPA in the absence and in the presence of spinal cord sensitization.The influence of the time course of inflammation and spinalization on the antinociceptive activity of the alpha2-adrenoceptor agonist medetomidine.The NSAID dexketoprofen trometamol is as potent as mu-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats.Response properties of hind limb single motor units in normal rats and after carrageenan-induced inflammation.Stimulus intensity, cell excitation and the N-methyl-D-aspartate receptor component of sensory responses in the rat spinal cord in vivo.Cutaneous responsiveness of lumbar spinal neurons in awake and halothane-anesthetized sheep.The dominant class of somatosensory neurone recorded in the spinal dorsal horn of awake sheep has wide dynamic range properties.Sensitization of spinal neurons by non-noxious stimuli in the awake but not anesthetized state.Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo.Biological activity of Leu-enkephalin containing hydrophobic moieties.Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes.Subeffective doses of nitroparacetamol (NCX-701) enhance the antinociceptive activity of the α2-adrenoceptor agonist medetomidineEnhancement of the analgesic activity of paracetamol and nitroparacetamol by the oral administration of all-trans retinoic acidA Critical Appraisal of COX-2 Selective Inhibition and Analgesia: How Good So Far?Male Wistar rats show uniform wind-up responses in carrageenan-induced inflammation but not in the normal situationAntinociceptive effects of metamizol (dipyrone) in rat single motor unitsAnalgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: Central and peripheral componentsCutaneous responsiveness of rat single motor units activated by natural stimulation
P50
Q21245243-168E3C6F-2975-484D-B8A1-669AF6BBDBD3Q24322842-7C785AA2-E58A-47FB-B8E0-C6A54CD0D3A9Q24685654-4B74FCEA-A081-4A13-8EC0-E1A996290A76Q33855413-F9D49641-D4B8-4878-9CBD-6C3FAC5C6E52Q34292925-E6FE6392-D580-4D2C-8F40-DEA8E67BB77FQ35552842-5E0A220D-9439-43A2-AAB0-22C4255FD1ECQ36951251-D2D24238-8C2F-4DBC-AEF2-E940CC10C159Q38961088-43C2398A-1D8A-4C7B-9866-822B8093E511Q38961105-6D92347D-6127-4523-AED1-B329E519AD04Q40537966-D9412233-8D9D-4659-BB2B-EB2B6FAE1D78Q41968343-A25D974F-77BA-4EA8-9FEB-6F48CF6B509AQ42105698-3DDD3EED-975C-4BE1-A3B6-12FD614A9B04Q42713255-8B476EEF-E4D8-4C0E-922A-E1450994AB2BQ43262079-0F526D7D-5415-464D-8D09-AF6FE6666384Q43263858-05EA1596-EAC5-4B71-BBC5-2B3D2FE4D427Q43621348-197A4B8F-BFD5-429B-A100-7F822E6987F8Q43978093-A499D774-5830-4927-AAB1-3E0157663E9EQ44352924-58F2C598-B2C1-4C54-98C6-0C613A1DEE5FQ44519075-3F7CE6E6-B2F1-42CB-8B26-3F292311662AQ45069039-BF44F51E-E17B-4729-BA56-E99EA37619E2Q45243877-944F297D-1D0C-4F1D-B188-8BEF80F622A9Q46489891-F8C3FE50-7CAC-4899-8BC3-49B916800B29Q46887539-ED4FA7CB-1E07-4426-95B0-331885350801Q46940698-FE9B1665-B8A0-4A8E-86EC-A0C0A884B1AFQ48312109-B4FB21E8-79D5-4699-99E0-B26EBC4D50DDQ51458395-1BD4EAD9-69D8-4483-9F3B-4E36E1D24034Q51537004-B149AB51-FC9B-4797-B2EF-10045D067FD0Q51592256-0407DF95-604D-4566-A58E-2633366C21D2Q51607625-7B35CC1E-DE15-4EB4-98FF-7123CEC5BBC4Q51614785-F769C863-9AAF-425B-BBDB-AF8FB27028D9Q51642827-0709E8EB-59CC-47C3-A971-10C3FDA6A9E8Q53885199-84675EEF-A865-435D-954F-3DBC0307B96BQ53961214-39DFA096-2EF9-4766-AA94-6F7187709271Q60772486-DE08159C-CA8A-41E4-9D45-82BFDDD187CFQ60772508-0390CBE1-DD73-403A-9775-5EAEE871BD98Q60772548-CCB9A34E-C902-4F34-BF87-ACBF1B85DC79Q60772562-ED640F08-C421-4C7D-A489-5FB8C8BBDEA6Q60772586-397C5219-FED3-4CBD-AAB2-6D63527ED1DBQ60772611-8F994611-5174-43E0-B4C7-13845162C108Q60772619-4633DB8C-36DC-4AA4-8B88-0C19E1DB87F5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Herrero JF
@ast
Herrero JF
@es
Herrero JF
@nl
Herrero JF
@sl
Juan F. Herrero
@en
type
label
Herrero JF
@ast
Herrero JF
@es
Herrero JF
@nl
Herrero JF
@sl
Juan F. Herrero
@en
altLabel
Herrero JF
@en
prefLabel
Herrero JF
@ast
Herrero JF
@es
Herrero JF
@nl
Herrero JF
@sl
Juan F. Herrero
@en
P106
P31
P496
0000-0003-1986-3482